Introduction {#sec1}
============

An accurate diagnosis of subepithelial lesions (SELs) in the gastrointestinal tract depends on a variety of methods: endoscopy, endoscopic ultrasound (EUS) and different types of biopsy. Making an error-free diagnosis is vital for the subsequent application of an appropriate treatment. Samples from the SELs for a histopathological evaluation should also be obtained.

Aim {#sec2}
===

The aim of our study was to evaluate the efficacy of deep biopsy via the endoscopic submucosal dissection (ESD) technique for SELs in the upper gastrointestinal tract.

Material and methods {#sec3}
====================

It was a case series study. Deep biopsy via the endoscopic submucosal dissection technique in upper gastrointestinal subepithelial lesions was completed in 38 patients between November 2012 and October 2014 at Vilnius University Hospital Santariskiu Clinics. The study protocol was authorized by the Vilnius Regional Research Ethics Committee with the Lithuanian Bioethics Committee, and written consent was obtained from all patients. The following inclusion criteria were met: (a) upper gastrointestinal tract solid subepithelial lesions of various sizes; (b) subepithelial lesions with a very prominent endophytic endoluminal growth pattern and an indistinct shape, not very prominent or exophytic growth pattern; (c) patients -- age between 18 and 80; (d) no coagulation abnormalities (prothrombin \> 50% and platelet count more than 50 000), no use of any anticoagulant; (e) confirmed by the patient's written consent. Exclusion criteria were: (a) refusal to provide informed consent; (b) pregnancy; (c) severe comorbidities.

All procedures were performed on an inpatient basis and intravenous sedation. Endoscopic ultrasound was performed with radial and linear instruments (Olympus GF UE160-AL5 and GF 140P-AL5). The size, shape, layer of origin, echogenicity, location and presumptive diagnosis were recorded. If solid, deep biopsy via endoscopic submucosal dissection in the intramural subepithelial lesion was performed. Most of the procedures were carried out by one experienced endoscopist, specialized in performing ESD for other gastric lesions. Deep biopsy ([Photos 1](#f0001){ref-type="fig"}--[4](#f0004){ref-type="fig"}) was performed under the direct endoscopic view (GIF-1TQ160; Olympus, Tokyo, Japan) in various sizes of SELs (very small ≤ 1 cm, small 1--2 cm and large ≥ 2 cm). To obtain a better localization for biopsy in most cases, a transparent cap (Olympus, reusable straight distal attachment) was used. Incision of the overlying layers in the most prominent lesion part was done without the injection of epinephrine saline solution. Several types of electrosurgical knives were employed (Triangle tip KD-640L, Dual knife KD-650L, Hook knife KD-620LR; Olympus). The aim of the dissection was to reveal the subepithelial lesion and to create enough area for forceps to perform the direct biopsies. Multiple biopsies were obtained by means of a reusable large round cup with needle biopsy forceps FB-50K-1 and reusable round cup biopsy forceps FB-25K-1, Olympus. In most cases the incision site was not fully closed. After the biopsies a prophylactic endoscopic hemostasis was performed using the injection of epinephrine diluted with saline solution 1 : 20 000, hot biopsies (AF 2423 DG, Alton), clipping (EZ Clip, HX-110QR, standard clip, Olympus) or, in a few cases, by ligating the lesion (ligating devise HX-21L-1, 13 mm loop, Olympus). For all patients an intravenous single esomeprazole infusion in a dosage of 40 mg was prescribed the same day after the procedure and per oral later. In order to eliminate late post biopsy bleeding, a repeated endoscopic examination and full blood count were conducted the next day after the procedure, as was a telephone survey after 1 week. Deep biopsy complications were defined as indicating non-intensive bleeding (bleeding stopped spontaneously without hemostasis), intensive bleeding (bleeding requiring endoscopic hemostasis with epinephrine injection, coagulation, clipping or ligation) and perforation (free air visible on abdominal scan).

![Incision of the overlying layers in the most prominent lesion part](WIITM-11-28044-g001){#f0001}

![Dissection and disclose of the subepithelial lesion](WIITM-11-28044-g002){#f0002}

![Biopsies with forceps under a direct endoscopic view](WIITM-11-28044-g003){#f0003}

![Clipping of the incision site](WIITM-11-28044-g004){#f0004}

Statistical analysis {#sec3.1}
--------------------

Acquired data were analyzed using SPSS version 17.0 for Windows and Microsoft Excel 2010. Continuous variables were expressed as mean ± SD, and categorical variables were denoted as frequency (%). Quantitative data were analyzed by the Mann-Whitney *U* test, while categorical variables were compared between groups using the χ^2^ or Fisher's exact test. The histopathological values of gastrointestinal stromal tumor (GIST) between the deep biopsy and after the resection were compared by means of Wilcoxon's matched-pairs signed-rank test. A *p*-value of less than 0.05 was considered to be statistically significant.

Results {#sec4}
=======

Deep biopsy via ESD technique for upper gastrointestinal tumors was performed in 38 patients. The main characteristics of the study population are summarized in [Table I](#t0001){ref-type="table"}. Most of them were asymptomatic or had nonspecific symptoms unrelated to the lesions, but one had dysphagia. Biopsies were mostly taken from lesions located in the stomach (*n* = 25, 66%), followed by a decreasing number in other locations: esophagus (*n* = 10, 26%) and duodenum (*n* = 3, 8%). The endoscopic examination revealed the following characteristics of the lesions concerning the shape and appearance of overlaying mucosa: clear endophytic growth with distinct margins (23; 60.5%) and with indistinct margins, not very prominent or exophytic growth pattern (15; 39.5%). The appearance of overlaying mucosa was normal in 33 (86.8%) and ulcerated or with mucosal ulcers after a previous "bite-on-bite" biopsy in 5 (13.2%). Only 1 case was diagnostic in 18 in whom biopsies according to the "bite-on-bite" technique were performed. Deep biopsy via the ESD technique was diagnostic in 28 of 38 patients (73.3%; 95% CI: 59.7--89.7%). The diagnostic yield for SELs with the clear endophytic shape increased to 91.3%.

###### 

Main characteristics of the study population

  Parameter                               Result
  --------------------------------------- --------------------
  Patients, *n*                           38
  Age (range) \[years\]                   58 ±12.4 (26--82)
  Gender, *n* (%):                        
   Male                                   14 (37)
   Female                                 24 (63)
  Mean size of SEL on EUS, range \[mm\]   20.4 ±11.7 (7--50)
  Location, *n* (%):                      
   Esophagus                              10 (26%)
   Stomach                                25 (66%)
   Duodenum                               3 (8%)

The deep biopsy complications were: non-intensive bleeding 21 (55.3%), intensive bleeding 2 (5.3%) and perforation in 1 (2.6%) case, which was suspected after nondiagnostic deep biopsy for the lesion with exophytic growth pattern and confirmed as free air visible on abdominal scan. Urgent surgery was performed. The patient follow-up was performed with an upper endoscopy the next day after biopsy and the telephone survey was conducted after 1 week. There were only 2 cases of non-severe bleeding (Forrest IIB) from the deep biopsy site on the next day after the procedure, and no complications were noted at 1 week.

Factors affecting the deep biopsy effectiveness in nondiagnostic and diagnostic groups are summarized in [Table II](#t0002){ref-type="table"}. An evident endophytic appearance of the subepithelial lesion, the mean number of biopsied samples (6.65 ±1.36) and the total size in length of all samples per case (19.88 ±8.07 mm) were the main criteria influencing the positiveness of deep biopsy. The pathological diagnoses are shown in [Table III](#t0003){ref-type="table"}. Most of the cases were leiomyomas, followed by GISTs. The deep biopsy was unable in all cases to correctly identify the mitotic count and the risk of GISTs because of insufficient high power fields (HPF), revealed by the pathological examination of biopsied specimens ([Tables IV](#t0004){ref-type="table"} and [V](#t0005){ref-type="table"}).

###### 

Factors affecting the deep biopsy effectiveness in nondiagnostic and diagnostic groups

  Parameter                   Nondiagnostic   Diagnostic     *P*-value
  --------------------------- --------------- -------------- -----------
  Patients, *n*               10              28             
  Age \[years\]:                                             
   Mean ± SD                  57.4 ±9.71      57.96 ±13.41   0.539
   Median (range)             54.5 (45--76)   61 (26--82)    
  Age \> 60 years, *n* (%)    4 (40)          15 (53.6)      0.714
  Gender, *n* (%):                                           
   Male                       5 (50)          9 (32.1)       0.449
   Female                     5 (50)          19 (67.9)      
  Localization, *n* (%):                                     
   Esophagus                  2 (20)          8 (28.6)       1
   Stomach                    7 (70)          18 (64.3)      
   Duodenum                   1 (10)          2 (7.1)        
  Shape, *n* (%):                                            
   Prominent                  2 (20)          21 (75)        0.001
   Non-prominent              8 (80)          7 (25)         
  Size EUS \[mm\], *n* (%):                                  
   ≤ 10                       4 (40)          5 (17.9)       0.232
   11--19                     4 (40)          10 (35.7)      
   ≥ 20                       2 (20)          13 (46.4)      
  Layer, *n*:                                                
   2^nd^                      2               3              0.406
   3^rd^                      3               6              
   4^th^                      4               18             
   Unknown                    1               1              
  Number of biopsies:                                        
   Mean ± SD                  5.33 ±1.5       6.65 ±1.36     0.025
   Median (range)             5 (2--7)        7 (4--10)      
  Total biopsy size \[mm\]:                                  
   Mean ± SD                  11.22 ±6.57     19.88 ±8.07    0.008
   Median (range)             12 (2--21)      20 (4--35)     
  Complications, *n* (%):                                    
   No bleeding                2 (20)          12 (42.9)      0.178
   Non-intensive bleeding     6 (60)          15 (53.6)      
   Intensive bleeding         1 (10)          1 (3.6)        
   Perforation                1 (10)          0 (0)          

###### 

Pathological results of deep biopsy

  Histology                                        Result, *n* (%)
  ------------------------------------------------ -----------------
  GIST                                             9 (23.7)
  Leiomyoma                                        13 (34.2)
  Lipoma                                           2 (5.3)
  Ectopic pancreas                                 2 (5.3)
  Brunner's gland hyperplasia                      1 (2.6)
  Mesenchymal tumor with low malignant potential   1 (2.6)
  Diagnostic                                       28 (73.7)
  Non-diagnostic                                   10 (26.3)
  Total                                            38 (100)

###### 

Prediction of GIST risk after deep biopsy and resected specimen

  Location   Size EUS \[mm\]   After deep biopsy   Size postoperative \[mm\]   After resection                  
  ---------- ----------------- ------------------- --------------------------- ----------------- ---- ---- ---- ----------
  Duodenum   35                1                   39                          --                37   2    50   Low
  Stomach    24                0                   23                          --                15   1    50   None
  Stomach    10                0                   3                           --                8    4    50   None
  Stomach    40                2                   45                          --                50   5    50   Very low
  Stomach    11                3                   50                          None              12   15   50   None
  Duodenum   15                0                   11                          --                14   1    50   None
  Stomach    31                0                   48                          --                25   4    50   Very low
  Stomach    45                1                   40                          --                --   --   --   --
  Stomach    27                2                   50                          Very low          33   7    50   Moderate

###### 

Prediction of GIST risk after deep biopsy and resected specimen

  Variable                   Biopsy         After resection   *P*-value
  -------------------------- -------------- ----------------- -----------
  Size (EUS vs. resection)   23.71 ±12.05   23 ±15.38         0.734
  24 (10--40)                15 (8--50)                       
  Mitotic rate               0.86 ±1.22     4.57 ±4.86        0.017
  0 (0--3)                   4 (1--15)                        
  HPF                        31.29 ±18.96   50 ±0             0.028
  39 (3--50)                 50 (50--50)                      

Discussion {#sec5}
==========

An accurate diagnosis of subepithelial lesions in the gastrointestinal tract depends on a variety of methods: endoscopy, EUS and different types of biopsy. Establishing an accurate diagnosis is vital for the subsequent application of appropriate treatment or follow-up. Thus, it is not enough to perform only EUS \[[@cit0001]\]. According to this study in 42.9% of cases in which preoperative EUS was performed but without a histological examination after surgery, they appeared to be benign. It seems that preoperative biopsy of SEL should be performed. However, there is no single management algorithm of these lesions.

Several recommendations regarding the management of SELs could be produced. The European Gastrointestinal Endoscopy Society (ESGE) suggests that esophageal SELs are rarely malignant and lesions \< 2 cm should not be biopsied, unless they are large and/or suspicious of malignancy. The management of gastric SELs depends on the lesion size, resectability and the patients' general health state being adequate to undergo the surgical procedure. If the lesion is small (\< 2 cm), it is unlikely to be affected by EUS-fine-needle aspiration (FNA) or EUS-Trucut biopsy (TCB), and surveillance seems to be the best option. If the gastric hypoechoic SEL is \> 2 cm, in three quarters of cases it will be GIST. The diagnostic yield of biopsy methods to determine the final lesion etiology and the mitotic index being low, the laparoscopic wedge resection of SEL in most patients is a safe option unless the patient is a poor surgical candidate or the tumor is located in areas difficult to resect, such as the cardia. EUS-FNA or EUS-TCB should be performed for a suspected unresectable GIST in which primary treatment with tyrosine kinase inhibitors is considered \[[@cit0002]\]. On the other hand, the European Society for Medical Oncology (ESMO)/European Sarcoma Network Working Group recommends that if the SEL has been confirmed histologically as a GIST and even if it is less than 2 cm, it should be surgically resected or, depending on the patient's age, life expectancy, and comorbidities, can be followed up. These small GISTs are actually of low risk; nevertheless, their clinical significance, progression to a higher risk level and follow-up rate are unclear. When the SELs are \< 2 cm and the etiology is unknown, the standard approach will be that of endoscopic ultrasound with a subsequent annual follow-up, reserving excision for patients whose tumor increases in size or become symptomatic \[[@cit0003]\]. There is no strong evidence to establish how often a follow-up examination should be performed. Both guidelines emphasize that SELs \> 2 cm are associated with higher risk, especially if they are in the stomach or hypoechogenic; in this case resection should be the first choice of management.

In the examination of SELs the most important aim is to differentiate GISTs from other hypoechogenic SELs. The gold standard to do this is with the help of an immunohistochemical analysis of biopsied specimens. Several biopsy methods for this purpose could be applied, such as: A) endoscopy controlled biopsies with small and large-capacity forceps using a bite-on-bite technique; B) "unroofing" and "keyhole" techniques; C) "deep" endoscopy controlled biopsies using the endoscopic submucosal dissection technique or mucosal-incision assisted biopsy (MIAB); D) EUS-guided, such as single-incision needle-knife biopsy (SINK), FNA and TCB. The diagnostic yield proved to vary widely: 17--100% ([Table VI](#t0006){ref-type="table"}). In the retrospective and prospective studies the diagnostic yield of EUS-FNA and EUS-TCB ranges from 43% to 100% and from 53% to 82% in the latter \[[@cit0004]\]. These biopsy methods have become standard (especially EUS-FNA) for the acquisition of tissue from the SELs. However, some disadvantages do exist, such as an insufficient tissue sample for immunohistochemical (IHC) staining and determining the mitotic index, especially for the evaluation of the malignant potential of the GIST \[[@cit0005]--[@cit0009]\].

###### 

Results of deep biopsy in other studies

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study            Study design    Lesions, *n*   Sampling technique                             Forceps type                           Complication rate *n*/%   Specimens                                                                 
  ---------------- --------------- -------------- ---------------------------------------------- -------------------------------------- ------------------------- ---------------------------------------------- -------------------------- ----
  \[[@cit0014]\]   Retrospective   36             Bite-on-bite                                   Large-capacity                         1/2.7                     42[§](#tf6-2){ref-type="table-fn"}             --                         --

  \[[@cit0015]\]   Prospective     23             Bite-on-bite                                   Large-capacity Radial Jaw 3            No                        17[§](#tf6-2){ref-type="table-fn"}             --                         --

  \[[@cit0016]\]   Retrospective   24             Bite-on-bite                                   Jumbo?                                 No                        25[†](#tf6-3){ref-type="table-fn"}             ?                          \+

  \[[@cit0017]\]   Prospective     37             Bite-on-bite                                   Conventional-size\                     5/14                      38                                             --                         --
                                                                                                 FB-25K-1                                                                                                                                   

  \[[@cit0018]\]   Retrospective   22             Bite-on-bite[‡](#tf6-4){ref-type="table-fn"}   Jumbo\                                 5/22                      91                                             ?                          ?
                                                                                                 Radial Jaw 4                                                                                                                               

  \[[@cit0019]\]   Retrospective   129            Bite-on-bite                                   Jumbo\                                 45/35                     59[¶](#tf6-1){ref-type="table-fn"}\            --                         --
                                                                                                 Radial Jaw 4                                                     65[§](#tf6-2){ref-type="table-fn"}\                                       
                                                                                                                                                                  40[†](#tf6-3){ref-type="table-fn"}                                        

  \[[@cit0020]\]   Case report     4              EUS-KB[ø](#tf6-5){ref-type="table-fn"}         Conventional-size                      No                        100%                                           \+                         \+

  \[[@cit0021]\]   Prospective     72             Jumbo biopsy "unroofing"                       Jumbo\                                 1/1.3                     92%                                            \+ (89%)                   \+
                                                                                                 Radial Jaw 4                                                                                                                               

  \[[@cit0022]\]   Prospective     16             EPR-UT[&](#tf6-6){ref-type="table-fn"}         Partially resected by snaring          9/56 (oozing)             94%                                            \+ (in all cases)          \+

  \[[@cit0011]\]   Retrospective   14             SINK[Ω](#tf6-7){ref-type="table-fn"}           Radial Jaw 4                           No                        93%                                            \+ (71% of cases)          \+

  \[[@cit0012]\]   Retrospective   27             MIAB[π](#tf6-8){ref-type="table-fn"}           Conventional biopsy forceps            No                        85%                                            \+ (almost in all cases)   \+

  \[[@cit0010]\]   Prospective     9              DB via ESD[Σ](#tf6-9){ref-type="table-fn"}     Standard biopsy forceps Radial Jaw 3   No                        100%                                           \+ (in all cases)          \+

  \[[@cit0001]\]   Prospective     40             DB via ESD[Σ](#tf6-9){ref-type="table-fn"}     Radial Jaw 3                           No                        90%                                            \+                         \+

  Our study        Prospective     38             DB via ESD[Σ](#tf6-9){ref-type="table-fn"}     Olympus\                               Non-intensive 21/55.3%\   73% overall 91% for clear endophytic lesions   \+ only in 2 cases of 9    \+
                                                                                                 FB-50K-1\                              Intensive\                                                                                          
                                                                                                 FB-25K-1                               2/5.3%\                                                                                             
                                                                                                                                        Perforation 1/2.6%                                                                                  
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Total diagnostic yield of bite-on-bite technique with jumbo biopsy forceps.

Diagnostic yield of bite-on-bite technique with jumbo biopsy forceps for subepithelial lesions from submucosa.

Diagnostic yield of bite-on-bite technique with jumbo biopsy forceps for subepithelial lesions from muscularis propria.

Bite-on-bite technique with jumbo biopsy forceps and touch-preparation cytology.

EUS-guided keyhole biopsy technique.

EPR-UT endoscopic partial resection using the unroofing technique.

EUS-guided single-incision with needle-knife (SINK) and deep forceps biopsies.

Mucosal-incision assisted biopsy (MIAB),

Deep biopsy via endoscopic submucosal dissection technique (DB via ESD).

Biopsies of SELs with the "bite-on-bite" technique in the most cases were non-diagnostic in our institution. Hence our aim was to determine the best option for the final pathological diagnosis of these SELs. Deep biopsy (DB) via endoscopic submucosal dissection (ESD) technique (DB via ESD) to the SEL was performed with a clear endophytic and not very prominent or exophytic shape. The overall diagnostic yield was 73.3%, which is lower than in other studies \[[@cit0001], [@cit0010]--[@cit0012]\]. However, the diagnostic yield for SELs with the clear endophytic shape increased to 91.3%.

No solution to the overlying layers of the SEL was injected before the incision. After the injection in some cases of SELs with a not very prominent shape, they became more flattening and it was difficult to locate an adequate incision location. This could have influenced the higher immediate non-intensive bleeding rate during biopsy in 21 (53.3%) of 38 patients. Intensive bleeding occurred in 2 patients and perforation in 1 (the SEL had an exophytic growth pattern). In most cases the incision site was not fully closed with clips. In cases of persistent bleeding or its prevention, clipping or partial ligation of the SEL after the deep biopsy was used. The risk of possible delayed post-biopsy bleeding was also evaluated. Only in 2 cases were blood clots in the post-biopsy site without active bleeding spotted the next day after the procedure and overall no complications after 1 week were noted.

The GIST are the most common mesenchymal neoplasms in the gastrointestinal tract and are most commonly found in the stomach. To differentiate them from other SELs, immunohistochemical analysis is required. The risk of progression and metastases depends on GIST size, location, and mitotic rate \[[@cit0013]\]. According to Miettinen *et al.* the malignant risk of GISTs could be nonexistent, very low, low, moderate or high. In our study 9 cases of GISTs were diagnosed and 8 of them had surgical or combined surgical and ESD resection with en bloc specimens for a pathological examination. The tumor size was correctly determined during endoscopic ultrasound comparing it with the postoperative specimen size ([Table V](#t0005){ref-type="table"}). In all cases an immunohistochemical analysis could be performed on the biopsy material. However, the overall size of the post-biopsy samples was insufficient in all cases to receive 50 HPF high power fields ([Tables IV](#t0004){ref-type="table"}, [V](#t0005){ref-type="table"}) and to determine the true lesion risk preoperatively. It was possible to evaluate a mitotic index only in 2 cases (5 and 9). Nevertheless, the risk of lesions in the 9^th^ case was underscored with the mitotic rate of 2/50 HPF and with a very low risk after the deep biopsy, compared to the higher mitotic rate of 7/50 HPF and a moderate risk of disease progression after the resection. In the 5^th^ GIST the mitotic rate was 15/50 HPF. According to Miettinen and Lasota, it is a rare group of tumors with few cases and with probably 0% risk. Therefore, compared to other studies, our results in determining the GIST mitotic rate were lower ([Table VI](#t0006){ref-type="table"}). The factors influencing this could be: first, too small size of the lesion (\< 15 mm in cases 3 and 6); second, the hard structure of the GIST made biopsy forceps glissade from the surface, and it was difficult to grasp the sample; and third, the type of biopsy forceps.

There are some limitations of the present study. Firstly, no comparison with other biopsy methods was made. Secondly, it was conducted in a single tertiary centre. Thirdly, most procedures were performed by one physician who had experience with ESD, and it is difficult to know what complication rate and what diagnostic yield would be achieved in other centers without such experience.

Conclusions {#sec6}
===========

Deep biopsy via the ESD technique is an effective and safe method for the diagnosis of SELs especially with a clear endophytic appearance in a large number of biopsied samples. This technique successfully differentiates SELs, particularly leiomyomas, from GISTs; however, in most cases it is difficult to determine the true risk of the latter. The size of SELs was measured correctly with endoscopic ultrasound, comparing it with the sample size after the resection; however, the mitotic count from biopsy samples could be correctly made only in a few cases. SELs with not very prominent or exophytic shape depending on size, location, patient's age, life expectancy, comorbidities, and GIST possibility should be followed up or biopsied with other techniques; otherwise, if an SEL is hypoechogenic and/or larger than \> 2 cm in the stomach, whether to directly perform a biopsy/excision with laparoscopic wedge resection is debatable.
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